[{"name": "pitavastatin", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " competitively inhibits HMG-Co"}, {"name": "pitavastatin", "prefix": "                 Absorption: ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " peak plasma concentrations ar"}, {"name": "pitavastatin", "prefix": " absolute bioavailability of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " oral solution is 51%. Adminis"}, {"name": "pitavastatin", "prefix": " (50% fat content) decreases ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax  by 43% but does not sig"}, {"name": "pitavastatin", "prefix": "oes not significantly reduce ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUC. The Cmax and AUC of pita"}, {"name": "pitavastatin", "prefix": "tin AUC. The Cmax and AUC of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " did not differ following even"}, {"name": "pitavastatin", "prefix": "hy volunteers receiving 4 mg ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": ", the percent change from base"}, {"name": "pitavastatin", "prefix": "at following morning dosing. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " was absorbed in the small int"}, {"name": "pitavastatin", "prefix": "               Distribution: ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " is more than 99% protein boun"}, {"name": "pitavastatin", "prefix": "ately 148 L.  Association of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " and/or its metabolites with t"}, {"name": "pitavastatin", "prefix": "                 Metabolism: ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " is marginally metabolized by "}, {"name": "pitavastatin", "prefix": " is formed via an ester-type ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " glucuronide conjugate by urid"}, {"name": "pitavastatin", "prefix": "d,  single 32 mg 14C-labeled ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " dose was excreted in urine, w"}, {"name": "pitavastatin", "prefix": ": In pharmacokinetic studies ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax and AUC were 21 and 5% l"}, {"name": "pitavastatin", "prefix": " male and female volunteers, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax and AUC were 60 and 54% "}, {"name": "pitavastatin", "prefix": "erly (\u226565\u00a0years) volunteers, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax and AUC were 10 and 30% "}, {"name": "pitavastatin", "prefix": "ease receiving hemodialysis, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUC0-inf is 102 and 86% highe"}, {"name": "pitavastatin", "prefix": "unteers, respectively, while ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax is 60 and 40% higher tha"}, {"name": "pitavastatin", "prefix": "odialysis immediately before ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " dosing and did not undergo he"}, {"name": "pitavastatin", "prefix": "the mean unbound fraction of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " as compared to healthy volunt"}, {"name": "pitavastatin", "prefix": "ercentage of protein-unbound ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " was approximately 0.6%.\n\n    "}, {"name": "pitavastatin", "prefix": " of mild renal impairment on ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " exposure has not been studied"}, {"name": "pitavastatin", "prefix": "pairment: The disposition of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " was compared in healthy volun"}, {"name": "pitavastatin", "prefix": "tic impairment. The ratio of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax between patients with mo"}, {"name": "pitavastatin", "prefix": "teers was 2.7.  The ratio of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUCinf between patients with "}, {"name": "pitavastatin", "prefix": "teers was 3.8.  The ratio of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax between patients with mi"}, {"name": "pitavastatin", "prefix": "teers was 1.3.  The ratio of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUCinf between patients with "}, {"name": "pitavastatin", "prefix": "hy volunteers was 1.6.  Mean ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " t\u00bd for moderate hepatic impai"}, {"name": "pitavastatin", "prefix": "ions: The principal route of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " metabolism is glucuronidation"}, {"name": "pitavastatin", "prefix": "with subsequent formation of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " lactone. There is only minima"}, {"name": "pitavastatin", "prefix": "T time or INR monitored when ", "fullId": "http://purl.bioontology.org/ontology/MESH/C108475", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " is added to their therapy.\n\n "}, {"name": "pitavastatin", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " competitively inhibits HMG-Co"}, {"name": "pitavastatin", "prefix": "                 Absorption: ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " peak plasma concentrations ar"}, {"name": "pitavastatin", "prefix": " absolute bioavailability of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " oral solution is 51%. Adminis"}, {"name": "pitavastatin", "prefix": " (50% fat content) decreases ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax  by 43% but does not sig"}, {"name": "pitavastatin", "prefix": "oes not significantly reduce ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUC. The Cmax and AUC of pita"}, {"name": "pitavastatin", "prefix": "tin AUC. The Cmax and AUC of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " did not differ following even"}, {"name": "pitavastatin", "prefix": "hy volunteers receiving 4 mg ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": ", the percent change from base"}, {"name": "pitavastatin", "prefix": "at following morning dosing. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " was absorbed in the small int"}, {"name": "pitavastatin", "prefix": "               Distribution: ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " is more than 99% protein boun"}, {"name": "pitavastatin", "prefix": "ately 148 L.  Association of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " and/or its metabolites with t"}, {"name": "pitavastatin", "prefix": "                 Metabolism: ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Pitavastatin", "suffix": " is marginally metabolized by "}, {"name": "pitavastatin", "prefix": " is formed via an ester-type ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " glucuronide conjugate by urid"}, {"name": "pitavastatin", "prefix": "d,  single 32 mg 14C-labeled ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " dose was excreted in urine, w"}, {"name": "pitavastatin", "prefix": ": In pharmacokinetic studies ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax and AUC were 21 and 5% l"}, {"name": "pitavastatin", "prefix": " male and female volunteers, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax and AUC were 60 and 54% "}, {"name": "pitavastatin", "prefix": "erly (\u226565\u00a0years) volunteers, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax and AUC were 10 and 30% "}, {"name": "pitavastatin", "prefix": "ease receiving hemodialysis, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUC0-inf is 102 and 86% highe"}, {"name": "pitavastatin", "prefix": "unteers, respectively, while ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax is 60 and 40% higher tha"}, {"name": "pitavastatin", "prefix": "odialysis immediately before ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " dosing and did not undergo he"}, {"name": "pitavastatin", "prefix": "the mean unbound fraction of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " as compared to healthy volunt"}, {"name": "pitavastatin", "prefix": "ercentage of protein-unbound ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " was approximately 0.6%.\n\n    "}, {"name": "pitavastatin", "prefix": " of mild renal impairment on ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " exposure has not been studied"}, {"name": "pitavastatin", "prefix": "pairment: The disposition of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " was compared in healthy volun"}, {"name": "pitavastatin", "prefix": "tic impairment. The ratio of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax between patients with mo"}, {"name": "pitavastatin", "prefix": "teers was 2.7.  The ratio of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUCinf between patients with "}, {"name": "pitavastatin", "prefix": "teers was 3.8.  The ratio of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " Cmax between patients with mi"}, {"name": "pitavastatin", "prefix": "teers was 1.3.  The ratio of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " AUCinf between patients with "}, {"name": "pitavastatin", "prefix": "hy volunteers was 1.6.  Mean ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " t\u00bd for moderate hepatic impai"}, {"name": "pitavastatin", "prefix": "ions: The principal route of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " metabolism is glucuronidation"}, {"name": "pitavastatin", "prefix": "with subsequent formation of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " lactone. There is only minima"}, {"name": "pitavastatin", "prefix": "T time or INR monitored when ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861634", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "pitavastatin", "suffix": " is added to their therapy.\n\n "}, {"name": "Cholesterol", "prefix": "nvolved with biosynthesis of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002784", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "cholesterol", "suffix": ", in a manner of competition w"}, {"name": "Cholesterol", "prefix": "ubstrate so that it inhibits ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002784", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "cholesterol", "suffix": " synthesis in the liver. As a "}, {"name": "Cholesterol", "prefix": " the sustained inhibition of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002784", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "cholesterol", "suffix": " synthesis in the liver decrea"}, {"name": "4-Way", "prefix": "e-blind, placebo-controlled, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/672535", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "4-way", "suffix": " parallel, active-comparator s"}, {"name": "moxifloxacin", "prefix": "active-comparator study with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/139462", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "moxifloxacin", "suffix": " in 174 healthy participants, "}, {"name": "moxifloxacin", "prefix": "active-comparator study with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C104727", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "moxifloxacin", "suffix": " in 174 healthy participants, "}, {"name": "Livalo", "prefix": "in 174 healthy participants, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " was not associated with clini"}, {"name": "Livalo", "prefix": "oportional manner for single ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " doses from 1 to 24 mg once da"}, {"name": "Livalo", "prefix": "on is 51%. Administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " with a high fat meal (50% fat"}, {"name": "Livalo", "prefix": "on the efficacy or safety of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " in women in clinical studies."}, {"name": "Livalo", "prefix": "on the efficacy or safety of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " in elderly subjects in clinic"}, {"name": "Livalo", "prefix": "dministered a single dose of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " 4 mg.  The AUC0-inf and the C"}, {"name": "Livalo", "prefix": " by the co-administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/861612", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "LIVALO", "suffix": " 4\u00a0mg daily. However, patients"}, {"name": "Warfarin", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Warfarin", "suffix": ": The steady-state pharmacodyn"}, {"name": "Warfarin", "prefix": "PT]) and pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "warfarin", "suffix": " in healthy volunteers were un"}, {"name": "Warfarin", "prefix": " However, patients receiving ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "warfarin", "suffix": " should have their PT time or "}, {"name": "Warfarin", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "Warfarin", "suffix": ": The steady-state pharmacodyn"}, {"name": "Warfarin", "prefix": "PT]) and pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "warfarin", "suffix": " in healthy volunteers were un"}, {"name": "Warfarin", "prefix": " However, patients receiving ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "warfarin", "suffix": " should have their PT time or "}, {"name": "Prothrombin", "prefix": "l normalized ratio [INR] and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011516", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "prothrombin", "suffix": " time [PT]) and pharmacokineti"}, {"name": "Prothrombin", "prefix": "l normalized ratio [INR] and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1441688", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": "prothrombin", "suffix": " time [PT]) and pharmacokineti"}, {"name": "hmg-coa", "prefix": "statin competitively inhibits", "fullId": "Added locally", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": " HMG-Co", "suffix": "A reductase, which is a rate-d"}, {"name": "glucuronide", "prefix": "ia an ester-type pitavastatin", "fullId": "Added locally", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": " glucuronid", "suffix": "e conjugate by uridine 5'-diph"}, {"name": "glycoprotein,", "prefix": "y to albumin and alpha 1-acid", "fullId": "Added locally", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": " glycoprotein", "suffix": ", and the mean volume of distr"}, {"name": "uridine", "prefix": "atin glucuronide conjugate by", "fullId": "Added locally", "setId": "44dcbf97-99ec-427c-ba50-207e0069d6d2", "exact": " uridin", "suffix": "e 5'-diphosphate (UDP) glucuro"}, {"name": "Eszopiclone", "prefix": "ecise mechanism of action of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " as a hypnotic is unknown, but"}, {"name": "Eszopiclone", "prefix": "o benzodiazepine receptors.  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is a nonbenzodiazepine hypnot"}, {"name": "Eszopiclone", "prefix": "     The pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " have been investigated in hea"}, {"name": "Eszopiclone", "prefix": " 1, 3, and 6 mg for 7 days.  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is rapidly absorbed, with a t"}, {"name": "Eszopiclone", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is rapidly absorbed following"}, {"name": "Eszopiclone", "prefix": " after oral administration.  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is weakly bound to plasma pro"}, {"name": "Eszopiclone", "prefix": " free fraction suggests that ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " disposition should not be aff"}, {"name": "Eszopiclone", "prefix": "he blood-to-plasma ratio for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is less than one, indicating "}, {"name": "Eszopiclone", "prefix": "llowing oral administration, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is extensively metabolized by"}, {"name": "Eszopiclone", "prefix": "tantially lower potency than ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ", and the former compound show"}, {"name": "Eszopiclone", "prefix": "nvolved in the metabolism of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ".  Eszopiclone did not show an"}, {"name": "Eszopiclone", "prefix": " metabolism of eszopiclone.  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " did not show any inhibitory p"}, {"name": "Eszopiclone", "prefix": "  After oral administration, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is eliminated with a mean t1/"}, {"name": "Eszopiclone", "prefix": "rofile would be expected for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ", the S-isomer of racemic zopi"}, {"name": "Eszopiclone", "prefix": "% of the orally administered ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " dose is excreted in the urine"}, {"name": "Eszopiclone", "prefix": "nistration of a 3 mg dose of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " after a high-fat meal resulte"}, {"name": "Eszopiclone", "prefix": "tly prolonged elimination of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " (t1/2 approximately 9\u00a0hours)."}, {"name": "Eszopiclone", "prefix": "     The pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " in men and women are similar."}, {"name": "Eszopiclone", "prefix": "pating in Phase 1 studies of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ", the pharmacokinetics for all"}, {"name": "Eszopiclone", "prefix": "  Pharmacokinetics of a 2 mg ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " dose were assessed in 16 heal"}, {"name": "Eszopiclone", "prefix": "     The pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " were studied in 24 patients w"}, {"name": "Eszopiclone", "prefix": "% of the orally administered ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " dose is excreted in the urine"}, {"name": "Eszopiclone", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is metabolized by CYP3A4 and "}, {"name": "Eszopiclone", "prefix": "dynamic interactions between ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " and paroxetine. When eszopicl"}, {"name": "Eszopiclone", "prefix": "piclone and paroxetine. When ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " was coadministered with olanz"}, {"name": "Eszopiclone", "prefix": "on was detected in levels of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " or olanzapine, but a pharmaco"}, {"name": "Eszopiclone", "prefix": "re of psychomotor function.  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " and lorazepam decreased each "}, {"name": "Eszopiclone", "prefix": "by 22%.  Coadministration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " 3 mg to subjects receiving ke"}, {"name": "Eszopiclone", "prefix": "fold increase in exposure to ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ".  Cmax and t1/2 were increase"}, {"name": "Eszopiclone", "prefix": "nistration of single dose of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " and paroxetine produced no ph"}, {"name": "Eszopiclone", "prefix": "istration of single doses of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " and lorazepam did not have cl"}, {"name": "Eszopiclone", "prefix": "  Digoxin:  A single dose of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " 3 mg did not affect the pharm"}, {"name": "Eszopiclone", "prefix": "                  Warfarin:  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " 3 mg administered daily for 5"}, {"name": "Eszopiclone", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is not highly bound to plasma"}, {"name": "Eszopiclone", "prefix": "herefore, the disposition of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is not expected to be sensiti"}, {"name": "Eszopiclone", "prefix": " binding.  Administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/461016", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " 3 mg to a patient taking anot"}, {"name": "eszopiclone", "prefix": "ecise mechanism of action of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " as a hypnotic is unknown, but"}, {"name": "eszopiclone", "prefix": "o benzodiazepine receptors.  ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is a nonbenzodiazepine hypnot"}, {"name": "eszopiclone", "prefix": "     The pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " have been investigated in hea"}, {"name": "eszopiclone", "prefix": " 1, 3, and 6 mg for 7 days.  ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is rapidly absorbed, with a t"}, {"name": "eszopiclone", "prefix": "6 hours.  In healthy adults, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " does not accumulate with once"}, {"name": "eszopiclone", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is rapidly absorbed following"}, {"name": "eszopiclone", "prefix": " after oral administration.  ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is weakly bound to plasma pro"}, {"name": "eszopiclone", "prefix": " free fraction suggests that ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " disposition should not be aff"}, {"name": "eszopiclone", "prefix": "he blood-to-plasma ratio for ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is less than one, indicating "}, {"name": "eszopiclone", "prefix": "llowing oral administration, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is extensively metabolized by"}, {"name": "eszopiclone", "prefix": "tantially lower potency than ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ", and the former compound show"}, {"name": "eszopiclone", "prefix": "nvolved in the metabolism of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ".  Eszopiclone did not show an"}, {"name": "eszopiclone", "prefix": " metabolism of eszopiclone.  ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " did not show any inhibitory p"}, {"name": "eszopiclone", "prefix": "  After oral administration, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is eliminated with a mean t1/"}, {"name": "eszopiclone", "prefix": "rofile would be expected for ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ", the S-isomer of racemic zopi"}, {"name": "eszopiclone", "prefix": "% of the orally administered ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " dose is excreted in the urine"}, {"name": "eszopiclone", "prefix": "nistration of a 3 mg dose of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " after a high-fat meal resulte"}, {"name": "eszopiclone", "prefix": "ely 6 hours.  The effects of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " on sleep onset may be reduced"}, {"name": "eszopiclone", "prefix": "tly prolonged elimination of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " (t1/2 approximately 9\u00a0hours)."}, {"name": "eszopiclone", "prefix": "     The pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " in men and women are similar."}, {"name": "eszopiclone", "prefix": "pating in Phase 1 studies of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ", the pharmacokinetics for all"}, {"name": "eszopiclone", "prefix": "  Pharmacokinetics of a 2 mg ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " dose were assessed in 16 heal"}, {"name": "eszopiclone", "prefix": "h severe hepatic impairment. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " should be used with caution i"}, {"name": "eszopiclone", "prefix": "     The pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " were studied in 24 patients w"}, {"name": "eszopiclone", "prefix": "% of the orally administered ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " dose is excreted in the urine"}, {"name": "eszopiclone", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is metabolized by CYP3A4 and "}, {"name": "eszopiclone", "prefix": "dynamic interactions between ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " and paroxetine. When eszopicl"}, {"name": "eszopiclone", "prefix": "piclone and paroxetine. When ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " was coadministered with olanz"}, {"name": "eszopiclone", "prefix": "on was detected in levels of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " or olanzapine, but a pharmaco"}, {"name": "eszopiclone", "prefix": "re of psychomotor function.  ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " and lorazepam decreased each "}, {"name": "eszopiclone", "prefix": "by 22%.  Coadministration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " 3 mg to subjects receiving ke"}, {"name": "eszopiclone", "prefix": "fold increase in exposure to ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": ".  Cmax and t1/2 were increase"}, {"name": "eszopiclone", "prefix": " and 1.3-fold, respectively. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " would not be expected to alte"}, {"name": "eszopiclone", "prefix": "nistration of single dose of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " and paroxetine produced no ph"}, {"name": "eszopiclone", "prefix": "istration of single doses of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " and lorazepam did not have cl"}, {"name": "eszopiclone", "prefix": "  Digoxin:  A single dose of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " 3 mg did not affect the pharm"}, {"name": "eszopiclone", "prefix": "                  Warfarin:  ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " 3 mg administered daily for 5"}, {"name": "eszopiclone", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Eszopiclone", "suffix": " is not highly bound to plasma"}, {"name": "eszopiclone", "prefix": "herefore, the disposition of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " is not expected to be sensiti"}, {"name": "eszopiclone", "prefix": " binding.  Administration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515051", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "eszopiclone", "suffix": " 3 mg to a patient taking anot"}, {"name": "gamma-Aminobutyric Acid", "prefix": "lt from its interaction with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D005680", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "GABA", "suffix": "-receptor complexes at binding"}, {"name": "gamma-Aminobutyric Acid", "prefix": "the latter compound binds to ", "fullId": "http://purl.bioontology.org/ontology/MESH/D005680", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "GABA", "suffix": " receptors with substantially "}, {"name": "Benzodiazepines", "prefix": "or allosterically coupled to ", "fullId": "http://purl.bioontology.org/ontology/MESH/D001569", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "benzodiazepine", "suffix": " receptors.  Eszopiclone is a "}, {"name": "Benzodiazepines", "prefix": "rimidines, imidazopyridines, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D001569", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "benzodiazepines", "suffix": ", barbiturates, or other drugs"}, {"name": "Lunesta", "prefix": "6 hours.  In healthy adults, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/540404", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " does not accumulate with once"}, {"name": "Lunesta", "prefix": "ely 6 hours.  The effects of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/540404", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " on sleep onset may be reduced"}, {"name": "Lunesta", "prefix": "h severe hepatic impairment. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/540404", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " should be used with caution i"}, {"name": "Lunesta", "prefix": " and 1.3-fold, respectively. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/540404", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "LUNESTA", "suffix": " would not be expected to alte"}, {"name": "zopiclone", "prefix": "y plasma metabolites are (S)-", "fullId": "http://purl.bioontology.org/ontology/RXNORM/40001", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": "-N-oxide and (S)-N-desmethyl z"}, {"name": "zopiclone", "prefix": "-N-oxide and (S)-N-desmethyl ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/40001", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": "; the latter compound binds to"}, {"name": "zopiclone", "prefix": "% of an oral dose of racemic ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/40001", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": " is excreted in the urine, pri"}, {"name": "zopiclone", "prefix": "one, the S-isomer of racemic ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/40001", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": ".  Less than 10% of the orally"}, {"name": "zopiclone", "prefix": "y plasma metabolites are (S)-", "fullId": "http://purl.bioontology.org/ontology/MESH/C515050", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": "-N-oxide and (S)-N-desmethyl z"}, {"name": "zopiclone", "prefix": "-N-oxide and (S)-N-desmethyl ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515050", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": "; the latter compound binds to"}, {"name": "zopiclone", "prefix": "% of an oral dose of racemic ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515050", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": " is excreted in the urine, pri"}, {"name": "zopiclone", "prefix": "one, the S-isomer of racemic ", "fullId": "http://purl.bioontology.org/ontology/MESH/C515050", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "zopiclone", "suffix": ".  Less than 10% of the orally"}, {"name": "Paroxetine", "prefix": "ions between eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "paroxetine", "suffix": ". When eszopiclone was coadmin"}, {"name": "Paroxetine", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Paroxetine", "suffix": ":  Coadministration of single "}, {"name": "Paroxetine", "prefix": "ngle dose of eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "paroxetine", "suffix": " produced no pharmacokinetic o"}, {"name": "Paroxetine", "prefix": "ions between eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "paroxetine", "suffix": ". When eszopiclone was coadmin"}, {"name": "Paroxetine", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Paroxetine", "suffix": ":  Coadministration of single "}, {"name": "Paroxetine", "prefix": "ngle dose of eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "paroxetine", "suffix": " produced no pharmacokinetic o"}, {"name": "olanzapine", "prefix": "lone was coadministered with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C076029", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "olanzapine", "suffix": ", no pharmacokinetic interacti"}, {"name": "olanzapine", "prefix": " in levels of eszopiclone or ", "fullId": "http://purl.bioontology.org/ontology/MESH/C076029", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "olanzapine", "suffix": ", but a pharmacodynamic intera"}, {"name": "olanzapine", "prefix": "lone was coadministered with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/61381", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "olanzapine", "suffix": ", no pharmacokinetic interacti"}, {"name": "olanzapine", "prefix": " in levels of eszopiclone or ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/61381", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "olanzapine", "suffix": ", but a pharmacodynamic intera"}, {"name": "Lorazepam", "prefix": "r function.  Eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6470", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "lorazepam", "suffix": " decreased each other's Cmax b"}, {"name": "Lorazepam", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6470", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Lorazepam", "suffix": ":  Coadministration of single "}, {"name": "Lorazepam", "prefix": "gle doses of eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6470", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "lorazepam", "suffix": " did not have clinically relev"}, {"name": "Lorazepam", "prefix": "r function.  Eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D008140", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "lorazepam", "suffix": " decreased each other's Cmax b"}, {"name": "Lorazepam", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/D008140", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Lorazepam", "suffix": ":  Coadministration of single "}, {"name": "Lorazepam", "prefix": "gle doses of eszopiclone and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D008140", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "lorazepam", "suffix": " did not have clinically relev"}, {"name": "Ketoconazole", "prefix": "e 3 mg to subjects receiving ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6135", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "ketoconazole", "suffix": ", a potent inhibitor of CYP3A4"}, {"name": "Ketoconazole", "prefix": "e 3 mg to subjects receiving ", "fullId": "http://purl.bioontology.org/ontology/MESH/D007654", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "ketoconazole", "suffix": ", a potent inhibitor of CYP3A4"}, {"name": "Digoxin", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3407", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Digoxin", "suffix": ":  A single dose of eszopiclon"}, {"name": "Digoxin", "prefix": "fect the pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3407", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "digoxin", "suffix": " measured at steady state foll"}, {"name": "Digoxin", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004077", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Digoxin", "suffix": ":  A single dose of eszopiclon"}, {"name": "Digoxin", "prefix": "fect the pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004077", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "digoxin", "suffix": " measured at steady state foll"}, {"name": "Warfarin", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Warfarin", "suffix": ":  Eszopiclone 3 mg administer"}, {"name": "Warfarin", "prefix": "rmacokinetics of (R)- or (S)-", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "warfarin", "suffix": ", nor were there any changes i"}, {"name": "Warfarin", "prefix": " a single 25 mg oral dose of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "warfarin", "suffix": ".\n\n                           "}, {"name": "Warfarin", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "Warfarin", "suffix": ":  Eszopiclone 3 mg administer"}, {"name": "Warfarin", "prefix": "rmacokinetics of (R)- or (S)-", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "warfarin", "suffix": ", nor were there any changes i"}, {"name": "Warfarin", "prefix": " a single 25 mg oral dose of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "warfarin", "suffix": ".\n\n                           "}, {"name": "Prothrombin", "prefix": "the pharmacodynamic profile (", "fullId": "http://purl.bioontology.org/ontology/MESH/D011516", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "prothrombin", "suffix": " time) following a single 25 m"}, {"name": "Prothrombin", "prefix": "the pharmacodynamic profile (", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1441688", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "prothrombin", "suffix": " time) following a single 25 m"}, {"name": "benzodiazepine", "prefix": "ceptors.  Eszopiclone is a no", "fullId": "Added locally", "setId": "39a5dae2-49f7-4662-9eac-aa7b4c7807a4", "exact": "nbenzodiazepin", "suffix": "e hypnotic that is a pyrrolopy"}, {"name": "Marplan", "prefix": "nyone considering the use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/152005", "setId": "ac387aa0-3f04-4865-a913-db6ed6f4fdc5", "exact": "Marplan", "suffix": " or any other antidepressant i"}, {"name": "Marplan", "prefix": "ication with the prescriber. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/152005", "setId": "ac387aa0-3f04-4865-a913-db6ed6f4fdc5", "exact": "Marplan", "suffix": " is not approved for use in pe"}, {"name": "Carbamazepine", "prefix": "yme inducing agents, such as ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2002", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "carbamazepine", "suffix": ", were found to significantly "}, {"name": "Carbamazepine", "prefix": "yme inducing agents, such as ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002220", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "carbamazepine", "suffix": ", were found to significantly "}, {"name": "Thiothixene", "prefix": "ly increase the clearance of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D013888", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "thiothixene", "suffix": ". Patients receiving these dru"}, {"name": "Thiothixene", "prefix": "bserved for signs of reduced ", "fullId": "http://purl.bioontology.org/ontology/MESH/D013888", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "thiothixene", "suffix": " effectiveness4,5.\n           "}, {"name": "Thiothixene", "prefix": "f excessive hypotension when ", "fullId": "http://purl.bioontology.org/ontology/MESH/D013888", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "thiothixene", "suffix": " is added to their drug regime"}, {"name": "Thiothixene", "prefix": "ly increase the clearance of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/10510", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "thiothixene", "suffix": ". Patients receiving these dru"}, {"name": "Thiothixene", "prefix": "bserved for signs of reduced ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/10510", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "thiothixene", "suffix": " effectiveness4,5.\n           "}, {"name": "Thiothixene", "prefix": "f excessive hypotension when ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/10510", "setId": "827cf470-485d-4925-85f2-8933a6dea830", "exact": "thiothixene", "suffix": " is added to their drug regime"}, {"name": "Dexfenfluramine", "prefix": "serotoninergic agents (e.g., ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020372", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "dexfenfluramine", "suffix": ", fluoxetine, fluvoxamine, par"}, {"name": "Dexfenfluramine", "prefix": "serotoninergic agents (e.g., ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3268", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "dexfenfluramine", "suffix": ", fluoxetine, fluvoxamine, par"}, {"name": "Fluoxetine", "prefix": "ents (e.g., dexfenfluramine, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/4493", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "fluoxetine", "suffix": ", fluvoxamine, paroxetine, ser"}, {"name": "Fluoxetine", "prefix": "ents (e.g., dexfenfluramine, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D005473", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "fluoxetine", "suffix": ", fluvoxamine, paroxetine, ser"}, {"name": "Fluvoxamine", "prefix": "dexfenfluramine, fluoxetine, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/42355", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "fluvoxamine", "suffix": ", paroxetine, sertraline, cita"}, {"name": "Fluvoxamine", "prefix": "dexfenfluramine, fluoxetine, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D016666", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "fluvoxamine", "suffix": ", paroxetine, sertraline, cita"}, {"name": "Paroxetine", "prefix": "ne, fluoxetine, fluvoxamine, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "paroxetine", "suffix": ", sertraline, citalopram, venl"}, {"name": "Paroxetine", "prefix": "ne, fluoxetine, fluvoxamine, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "paroxetine", "suffix": ", sertraline, citalopram, venl"}, {"name": "Sertraline", "prefix": "ne, fluvoxamine, paroxetine, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "sertraline", "suffix": ", citalopram, venlafaxine) the"}, {"name": "Sertraline", "prefix": "ne, fluvoxamine, paroxetine, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "sertraline", "suffix": ", citalopram, venlafaxine) the"}, {"name": "Citalopram", "prefix": "ine, paroxetine, sertraline, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D015283", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "citalopram", "suffix": ", venlafaxine) there have been"}, {"name": "Citalopram", "prefix": "ine, paroxetine, sertraline, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2556", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "citalopram", "suffix": ", venlafaxine) there have been"}, {"name": "venlafaxine", "prefix": "ine, sertraline, citalopram, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C047426", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "venlafaxine", "suffix": ") there have been reports of s"}, {"name": "venlafaxine", "prefix": "ine, sertraline, citalopram, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/39786", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "venlafaxine", "suffix": ") there have been reports of s"}, {"name": "Nardil", "prefix": "es fatal, reactions. Because ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/203799", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "NARDIL", "suffix": " is a monoamine oxidase (MAO) "}, {"name": "Nardil", "prefix": "ine oxidase (MAO) inhibitor, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/203799", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "NARDIL", "suffix": " should not be used concomitan"}, {"name": "Phenelzine", "prefix": "es fatal, reactions. Because ", "fullId": "http://purl.bioontology.org/ontology/MESH/D010624", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "NARDIL", "suffix": " is a monoamine oxidase (MAO) "}, {"name": "Phenelzine", "prefix": "ine oxidase (MAO) inhibitor, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D010624", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "NARDIL", "suffix": " should not be used concomitan"}, {"name": "Guanethidine", "prefix": "           Administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/5036", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "guanethidine", "suffix": " to patients receiving an MAO "}, {"name": "Guanethidine", "prefix": "ibitor and the initiation of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/5036", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "guanethidine", "suffix": ". (see CONTRAINDICATIONS)\n    "}, {"name": "Guanethidine", "prefix": "           Administration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D006145", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "guanethidine", "suffix": " to patients receiving an MAO "}, {"name": "Guanethidine", "prefix": "ibitor and the initiation of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D006145", "setId": "513a41d0-37d4-4355-8a6d-a2c643bce6fa", "exact": "guanethidine", "suffix": ". (see CONTRAINDICATIONS)\n    "}, {"name": "Doxepin", "prefix": " \n                  Although ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " HCl does have H1 and H2 hista"}, {"name": "Doxepin", "prefix": "the exact mechanism by which ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " exerts its antipruritic effec"}, {"name": "Doxepin", "prefix": "ipruritic effect is unknown. ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "PRUDOXIN", "suffix": " Cream can produce drowsiness "}, {"name": "Doxepin", "prefix": "eczema patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "PRUDOXIN", "suffix": " Cream, plasma doxepin concent"}, {"name": "Doxepin", "prefix": " with PRUDOXIN Cream, plasma ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " concentrations ranged from no"}, {"name": "Doxepin", "prefix": " from topical application of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "PRUDOXIN", "suffix": " Cream can result in CNS and o"}, {"name": "Doxepin", "prefix": "to the systemic circulation, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " undergoes hepatic metabolism "}, {"name": "Doxepin", "prefix": "osing. Plasma levels of both ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " and desmethyldoxepin are high"}, {"name": "Doxepin", "prefix": "nd subsequent elimination of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004316", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": ". (See PRECAUTIONS - Drug Inte"}, {"name": "Doxepin", "prefix": " \n                  Although ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3638", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " HCl does have H1 and H2 hista"}, {"name": "Doxepin", "prefix": "the exact mechanism by which ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3638", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " exerts its antipruritic effec"}, {"name": "Doxepin", "prefix": " with PRUDOXIN Cream, plasma ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3638", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " concentrations ranged from no"}, {"name": "Doxepin", "prefix": "to the systemic circulation, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3638", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " undergoes hepatic metabolism "}, {"name": "Doxepin", "prefix": "osing. Plasma levels of both ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3638", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": " and desmethyldoxepin are high"}, {"name": "Doxepin", "prefix": "nd subsequent elimination of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3638", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "doxepin", "suffix": ". (See PRECAUTIONS - Drug Inte"}, {"name": "Histamine", "prefix": "epin HCl does have H1 and H2 ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/5333", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "histamine", "suffix": " receptor blocking actions, th"}, {"name": "Histamine", "prefix": "epin HCl does have H1 and H2 ", "fullId": "http://purl.bioontology.org/ontology/MESH/D006632", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "histamine", "suffix": " receptor blocking actions, th"}, {"name": "Prudoxin", "prefix": "ipruritic effect is unknown. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/261625", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "PRUDOXIN", "suffix": " Cream can produce drowsiness "}, {"name": "Prudoxin", "prefix": "eczema patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/261625", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "PRUDOXIN", "suffix": " Cream, plasma doxepin concent"}, {"name": "Prudoxin", "prefix": " from topical application of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/261625", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "PRUDOXIN", "suffix": " Cream can result in CNS and o"}, {"name": "desmethyldoxepin", "prefix": " to pharmacologically-active ", "fullId": "http://purl.bioontology.org/ontology/MESH/C028701", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "desmethyldoxepin", "suffix": ". Further glucuronidation resu"}, {"name": "desmethyldoxepin", "prefix": "nt drug and its metabolites. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C028701", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "Desmethyldoxepin", "suffix": " has a half-life that ranges f"}, {"name": "desmethyldoxepin", "prefix": "a levels of both doxepin and ", "fullId": "http://purl.bioontology.org/ontology/MESH/C028701", "setId": "c66a11c1-3093-45ef-b348-3b196c05ba0c", "exact": "desmethyldoxepin", "suffix": " are highly variable and are p"}, {"name": "mirtazapine", "prefix": " upon the discontinuation of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " (mirtazapine) Tablets (partic"}, {"name": "mirtazapine", "prefix": " discontinuation of REMERON (", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ") Tablets (particularly when a"}, {"name": "mirtazapine", "prefix": "   Patients currently taking ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " should NOT discontinue treatm"}, {"name": "mirtazapine", "prefix": "o discontinue treatment with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", a gradual reduction in the d"}, {"name": "mirtazapine", "prefix": " very rarely with the use of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ". Caution should be exercised "}, {"name": "mirtazapine", "prefix": "54% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " (mirtazapine) Tablets, compar"}, {"name": "mirtazapine", "prefix": "tients treated with REMERON (", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ") Tablets, compared to 18% for"}, {"name": "mirtazapine", "prefix": "discontinuation for 10.4% of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": "-treated patients, compared to"}, {"name": "mirtazapine", "prefix": " to the somnolent effects of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ". Because of the potentially s"}, {"name": "mirtazapine", "prefix": "ially significant effects of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " on impairment of performance,"}, {"name": "mirtazapine", "prefix": " 7% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", compared to 3% for placebo a"}, {"name": "mirtazapine", "prefix": " association with the use of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ".\n                           \n"}, {"name": "mirtazapine", "prefix": "17% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", compared to 2% for placebo a"}, {"name": "mirtazapine", "prefix": ".5% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ", compared to 0% for placebo a"}, {"name": "mirtazapine", "prefix": "nt, 8% of patients receiving ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " discontinued for weight gain."}, {"name": "mirtazapine", "prefix": "ween 15 to 45 mg/day, 49% of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": "-treated patients had a weight"}, {"name": "mirtazapine", "prefix": "15% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", compared to 7% for placebo a"}, {"name": "mirtazapine", "prefix": " 6% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ", compared to 3% for placebo a"}, {"name": "mirtazapine", "prefix": "/424) of patients exposed to ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " in a pool of short-term US co"}, {"name": "mirtazapine", "prefix": " to normal despite continued ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " treatment. REMERON should be "}, {"name": "mirtazapine", "prefix": "continued REMERON treatment. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " should be used with caution i"}, {"name": "mirtazapine", "prefix": "ly 0.2% (3/1299 patients) of ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": "-treated patients in US studie"}, {"name": "mirtazapine", "prefix": "ry low during treatment with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ", it should be used carefully "}, {"name": "mirtazapine", "prefix": "non-US patients treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ". However, no controlled studi"}, {"name": "mirtazapine", "prefix": "are should be exercised when ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": " is used in these patients.\n  "}, {"name": "mirtazapine", "prefix": "    Clinical experience with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " in patients with concomitant "}, {"name": "mirtazapine", "prefix": " is advisable in prescribing ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": " for patients with diseases or"}, {"name": "mirtazapine", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " has not been systematically e"}, {"name": "mirtazapine", "prefix": "r significant heart disease. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " was associated with significa"}, {"name": "mirtazapine", "prefix": "als with depressed patients. ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " should be used with caution i"}, {"name": "mirtazapine", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/C035133", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "Mirtazapine", "suffix": " clearance is decreased in pat"}, {"name": "Remeron", "prefix": " upon the discontinuation of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " (mirtazapine) Tablets (partic"}, {"name": "Remeron", "prefix": "   Patients currently taking ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " should NOT discontinue treatm"}, {"name": "Remeron", "prefix": "o discontinue treatment with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", a gradual reduction in the d"}, {"name": "Remeron", "prefix": "54% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " (mirtazapine) Tablets, compar"}, {"name": "Remeron", "prefix": "discontinuation for 10.4% of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": "-treated patients, compared to"}, {"name": "Remeron", "prefix": " to the somnolent effects of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ". Because of the potentially s"}, {"name": "Remeron", "prefix": "ially significant effects of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " on impairment of performance,"}, {"name": "Remeron", "prefix": " 7% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", compared to 3% for placebo a"}, {"name": "Remeron", "prefix": " association with the use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ".\n                           \n"}, {"name": "Remeron", "prefix": "17% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", compared to 2% for placebo a"}, {"name": "Remeron", "prefix": "nt, 8% of patients receiving ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " discontinued for weight gain."}, {"name": "Remeron", "prefix": "ween 15 to 45 mg/day, 49% of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": "-treated patients had a weight"}, {"name": "Remeron", "prefix": "15% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ", compared to 7% for placebo a"}, {"name": "Remeron", "prefix": "/424) of patients exposed to ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " in a pool of short-term US co"}, {"name": "Remeron", "prefix": " to normal despite continued ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " treatment. REMERON should be "}, {"name": "Remeron", "prefix": "continued REMERON treatment. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " should be used with caution i"}, {"name": "Remeron", "prefix": "ly 0.2% (3/1299 patients) of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": "-treated patients in US studie"}, {"name": "Remeron", "prefix": "non-US patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": ". However, no controlled studi"}, {"name": "Remeron", "prefix": "    Clinical experience with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " in patients with concomitant "}, {"name": "Remeron", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " has not been systematically e"}, {"name": "Remeron", "prefix": "r significant heart disease. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " was associated with significa"}, {"name": "Remeron", "prefix": "als with depressed patients. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/134774", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "REMERON", "suffix": " should be used with caution i"}, {"name": "Mirtazapine", "prefix": " discontinuation of REMERON (", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ") Tablets (particularly when a"}, {"name": "Mirtazapine", "prefix": " very rarely with the use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ". Caution should be exercised "}, {"name": "Mirtazapine", "prefix": "tients treated with REMERON (", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ") Tablets, compared to 18% for"}, {"name": "Mirtazapine", "prefix": ".5% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ", compared to 0% for placebo a"}, {"name": "Mirtazapine", "prefix": " 6% of patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ", compared to 3% for placebo a"}, {"name": "Mirtazapine", "prefix": "ry low during treatment with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": ", it should be used carefully "}, {"name": "Mirtazapine", "prefix": "are should be exercised when ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": " is used in these patients.\n  "}, {"name": "Mirtazapine", "prefix": " is advisable in prescribing ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "mirtazapine", "suffix": " for patients with diseases or"}, {"name": "Mirtazapine", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/15996", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "Mirtazapine", "suffix": " clearance is decreased in pat"}, {"name": "Amitriptyline", "prefix": " 18% for placebo and 60% for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In these studies, somnolence"}, {"name": "Amitriptyline", "prefix": "o 3% for placebo and 14% for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". It is unclear whether or not"}, {"name": "Amitriptyline", "prefix": "to 2% for placebo and 6% for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In these same trials, weight"}, {"name": "Amitriptyline", "prefix": " 0% for placebo and 5.9% for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In a pool of premarketing US"}, {"name": "Amitriptyline", "prefix": "to 7% for placebo and 8% for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In these same studies, nonfa"}, {"name": "Amitriptyline", "prefix": "to 3% for placebo and 3% for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ".\n                           \n"}, {"name": "Amitriptyline", "prefix": "patients and 2.0% (3/181) of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/704", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": " patients. Most of these patie"}, {"name": "Amitriptyline", "prefix": " 18% for placebo and 60% for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In these studies, somnolence"}, {"name": "Amitriptyline", "prefix": "o 3% for placebo and 14% for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". It is unclear whether or not"}, {"name": "Amitriptyline", "prefix": "to 2% for placebo and 6% for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In these same trials, weight"}, {"name": "Amitriptyline", "prefix": " 0% for placebo and 5.9% for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In a pool of premarketing US"}, {"name": "Amitriptyline", "prefix": "to 7% for placebo and 8% for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ". In these same studies, nonfa"}, {"name": "Amitriptyline", "prefix": "to 3% for placebo and 3% for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": ".\n                           \n"}, {"name": "Amitriptyline", "prefix": "patients and 2.0% (3/181) of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D000639", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "amitriptyline", "suffix": " patients. Most of these patie"}, {"name": "Cholesterol", "prefix": " \n                           ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002784", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "Cholesterol", "suffix": "/Triglycerides\n               "}, {"name": "Cholesterol", "prefix": "ntrolled studies, nonfasting ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002784", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "cholesterol", "suffix": " increases to \u226520% above the u"}, {"name": "triglyceride", "prefix": "                  Cholesterol", "fullId": "Added locally", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": "/Triglycerid", "suffix": "es\n                           "}, {"name": "triglyceride", "prefix": "hese same studies, nonfasting", "fullId": "Added locally", "setId": "010f9162-9f7f-4b6d-a6e4-4f832f26f38e", "exact": " triglycerid", "suffix": "e increases to \u2265500 mg/dL were"}, {"name": "Clomipramine Hydrochloride", "prefix": "          \n                  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/81984", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "Clomipramine hydrochloride", "suffix": " capsules USP are contraindica"}, {"name": "Clomipramine", "prefix": "          \n                  ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "Clomipramine hydrochloride", "suffix": " capsules USP are contraindica"}, {"name": "Clomipramine", "prefix": "story of hypersensitivity to ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " or other tricyclic antidepres"}, {"name": "Clomipramine", "prefix": "t psychiatric disorders with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " or within 14 days of stopping"}, {"name": "Clomipramine", "prefix": "s of stopping treatment with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " is contraindicated because of"}, {"name": "Clomipramine", "prefix": "rotonin syndrome. The use of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " within 14 days of stopping an"}, {"name": "Clomipramine", "prefix": "                    Starting ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " in a patient who is being tre"}, {"name": "Clomipramine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002997", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "Clomipramine", "suffix": " is contraindicated during the"}, {"name": "Clomipramine", "prefix": "story of hypersensitivity to ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2597", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " or other tricyclic antidepres"}, {"name": "Clomipramine", "prefix": "t psychiatric disorders with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2597", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " or within 14 days of stopping"}, {"name": "Clomipramine", "prefix": "s of stopping treatment with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2597", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " is contraindicated because of"}, {"name": "Clomipramine", "prefix": "rotonin syndrome. The use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2597", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " within 14 days of stopping an"}, {"name": "Clomipramine", "prefix": "                    Starting ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2597", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "clomipramine", "suffix": " in a patient who is being tre"}, {"name": "Clomipramine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2597", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "Clomipramine", "suffix": " is contraindicated during the"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "serotonin", "suffix": " syndrome. The use of clomipra"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "serotonin", "suffix": " syndrome (see \n              "}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "serotonin", "suffix": " syndrome. The use of clomipra"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "serotonin", "suffix": " syndrome (see \n              "}, {"name": "linezolid", "prefix": "nt who is being treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/190376", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "linezolid", "suffix": " or intravenous methylene blue"}, {"name": "linezolid", "prefix": "nt who is being treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C098010", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "linezolid", "suffix": " or intravenous methylene blue"}, {"name": "Methylene Blue", "prefix": "ith linezolid or intravenous ", "fullId": "http://purl.bioontology.org/ontology/MESH/D008751", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "methylene blue", "suffix": " is also contraindicated becau"}, {"name": "Methylene blue", "prefix": "ith linezolid or intravenous ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6878", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "methylene blue", "suffix": " is also contraindicated becau"}, {"name": "maoi", "prefix": "Monoamine Oxidase Inhibitors ", "fullId": "Added locally", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": "(MAO", "suffix": "Is)\n                     \n    "}, {"name": "maoi", "prefix": "                   The use of", "fullId": "Added locally", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": " MAO", "suffix": "Is intended to treat psychiatr"}, {"name": "maoi", "prefix": "within 14 days of stopping an", "fullId": "Added locally", "setId": "1809bcb4-5fcc-45ca-986a-4fa5edcd4b5e", "exact": " MAO", "suffix": "I intended to treat psychiatri"}, {"name": "Clozapine", "prefix": "  The mechanism of action of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " is unknown. However, it has b"}, {"name": "Clozapine", "prefix": " the therapeutic efficacy of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " in schizophrenia is mediated "}, {"name": "Clozapine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " demonstrated binding affinity"}, {"name": "Clozapine", "prefix": "M). \n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " causes little or no prolactin"}, {"name": "Clozapine", "prefix": "G) studies demonstrated that ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " increases delta and theta act"}, {"name": "Clozapine", "prefix": "ion of dream activity during ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " therapy. REM sleep was found "}, {"name": "Clozapine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " is approximately 97% bound to"}, {"name": "Clozapine", "prefix": "ins. The interaction between ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and other highly protein-boun"}, {"name": "Clozapine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " is almost completely metaboli"}, {"name": "Clozapine", "prefix": "cted in the urine and feces. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " is a substrate for many cytoc"}, {"name": "Clozapine", "prefix": "ean elimination half-life of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " after a single 75 mg dose was"}, {"name": "Clozapine", "prefix": "tiple-dose administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " demonstrated that the elimina"}, {"name": "Clozapine", "prefix": "rve (AUC), peak, and minimum ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " plasma concentrations were ob"}, {"name": "Clozapine", "prefix": "hrenic patients who received ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " under steady-state conditions"}, {"name": "Clozapine", "prefix": "ean trough concentrations of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and its metabolites, N-desmet"}, {"name": "Clozapine", "prefix": "patients (n=14) who received ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " under steady-state conditions"}, {"name": "Clozapine", "prefix": "nor changes in the levels of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and its metabolites. However,"}, {"name": "Clozapine", "prefix": "ations (less than 2-fold) of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and metabolite concentrations"}, {"name": "Clozapine", "prefix": "tabolite concentrations when ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " was taken with paroxetine, fl"}, {"name": "Clozapine", "prefix": "t on the pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": ". Higher clozapine plasma conc"}, {"name": "Clozapine", "prefix": "inetics of clozapine. Higher ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " plasma concentrations are lik"}, {"name": "Clozapine", "prefix": "ted plasma concentrations of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2626", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " when given usual doses.\n     "}, {"name": "Clozapine", "prefix": "  The mechanism of action of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " is unknown. However, it has b"}, {"name": "Clozapine", "prefix": " the therapeutic efficacy of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " in schizophrenia is mediated "}, {"name": "Clozapine", "prefix": " type 2A (5-HT2A) receptors. ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " also acts as an antagonist at"}, {"name": "Clozapine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " demonstrated binding affinity"}, {"name": "Clozapine", "prefix": "M). \n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " causes little or no prolactin"}, {"name": "Clozapine", "prefix": "G) studies demonstrated that ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " increases delta and theta act"}, {"name": "Clozapine", "prefix": "ion of dream activity during ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " therapy. REM sleep was found "}, {"name": "Clozapine", "prefix": "                  In humans, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " tablets (25 mg and 100 mg) ar"}, {"name": "Clozapine", "prefix": "y bioavailable relative to a ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " solution. Following oral admi"}, {"name": "Clozapine", "prefix": "owing oral administration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " 100 mg twice daily, the avera"}, {"name": "Clozapine", "prefix": " systemic bioavailability of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": ". Thus, CLOZARIL may be admini"}, {"name": "Clozapine", "prefix": "ilability of CLOZARIL. Thus, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " may be administered with or w"}, {"name": "Clozapine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " is approximately 97% bound to"}, {"name": "Clozapine", "prefix": "ins. The interaction between ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and other highly protein-boun"}, {"name": "Clozapine", "prefix": "    \n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " is almost completely metaboli"}, {"name": "Clozapine", "prefix": "cted in the urine and feces. ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Clozapine", "suffix": " is a substrate for many cytoc"}, {"name": "Clozapine", "prefix": "ean elimination half-life of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " after a single 75 mg dose was"}, {"name": "Clozapine", "prefix": "tiple-dose administration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " demonstrated that the elimina"}, {"name": "Clozapine", "prefix": "rve (AUC), peak, and minimum ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " plasma concentrations were ob"}, {"name": "Clozapine", "prefix": "hrenic patients who received ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " under steady-state conditions"}, {"name": "Clozapine", "prefix": "ean trough concentrations of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and its metabolites, N-desmet"}, {"name": "Clozapine", "prefix": "patients (n=14) who received ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " under steady-state conditions"}, {"name": "Clozapine", "prefix": "nor changes in the levels of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and its metabolites. However,"}, {"name": "Clozapine", "prefix": "ations (less than 2-fold) of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " and metabolite concentrations"}, {"name": "Clozapine", "prefix": "tabolite concentrations when ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " was taken with paroxetine, fl"}, {"name": "Clozapine", "prefix": "t on the pharmacokinetics of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": ". Higher clozapine plasma conc"}, {"name": "Clozapine", "prefix": "inetics of clozapine. Higher ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " plasma concentrations are lik"}, {"name": "Clozapine", "prefix": "ted plasma concentrations of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003024", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "clozapine", "suffix": " when given usual doses.\n     "}, {"name": "Dopamine", "prefix": "ed through antagonism of the ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3628", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " type 2 (D2) and the serotonin"}, {"name": "Dopamine", "prefix": "erotonin 5-HT2C (Ki 9.4 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3628", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D4 (Ki 24 nM), adrenergic \u03b12A"}, {"name": "Dopamine", "prefix": "erotonin 5-HT1A (Ki 120 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3628", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D2 (Ki 160 nM), dopamine D1 ("}, {"name": "Dopamine", "prefix": "M), dopamine D2 (Ki 160 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3628", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D1 (Ki 270 nM), dopamine D5 ("}, {"name": "Dopamine", "prefix": "M), dopamine D1 (Ki 270 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3628", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D5 (Ki 454 nM), and dopamine "}, {"name": "Dopamine", "prefix": "dopamine D5 (Ki 454 nM), and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3628", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D3 (Ki 555 nM). \n            "}, {"name": "Dopamine", "prefix": "ed through antagonism of the ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004298", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " type 2 (D2) and the serotonin"}, {"name": "Dopamine", "prefix": "erotonin 5-HT2C (Ki 9.4 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004298", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D4 (Ki 24 nM), adrenergic \u03b12A"}, {"name": "Dopamine", "prefix": "erotonin 5-HT1A (Ki 120 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004298", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D2 (Ki 160 nM), dopamine D1 ("}, {"name": "Dopamine", "prefix": "M), dopamine D2 (Ki 160 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004298", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D1 (Ki 270 nM), dopamine D5 ("}, {"name": "Dopamine", "prefix": "M), dopamine D1 (Ki 270 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004298", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D5 (Ki 454 nM), and dopamine "}, {"name": "Dopamine", "prefix": "dopamine D5 (Ki 454 nM), and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004298", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "dopamine", "suffix": " D3 (Ki 555 nM). \n            "}, {"name": "Serotonin", "prefix": "dopamine type 2 (D2) and the ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " type 2A (5-HT2A) receptors. C"}, {"name": "Serotonin", "prefix": " adrenergic \u03b11A (Ki 1.6 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT6 (Ki 4 nM), serotonin 5-"}, {"name": "Serotonin", "prefix": ", serotonin 5-HT6 (Ki 4 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT2A (Ki 5.4 nM), muscarini"}, {"name": "Serotonin", "prefix": ", muscarinic M1 (Ki 6.2 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT7 (Ki 6.3 nM), serotonin "}, {"name": "Serotonin", "prefix": "serotonin 5-HT7 (Ki 6.3 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT2C (Ki 9.4 nM), dopamine "}, {"name": "Serotonin", "prefix": ", adrenergic \u03b12A (Ki 90 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT3 (Ki 95 nM), serotonin 5"}, {"name": "Serotonin", "prefix": " serotonin 5-HT3 (Ki 95 nM), ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT1A (Ki 120 nM), dopamine "}, {"name": "Serotonin", "prefix": "dopamine type 2 (D2) and the ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " type 2A (5-HT2A) receptors. C"}, {"name": "Serotonin", "prefix": " adrenergic \u03b11A (Ki 1.6 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT6 (Ki 4 nM), serotonin 5-"}, {"name": "Serotonin", "prefix": ", serotonin 5-HT6 (Ki 4 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT2A (Ki 5.4 nM), muscarini"}, {"name": "Serotonin", "prefix": ", muscarinic M1 (Ki 6.2 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT7 (Ki 6.3 nM), serotonin "}, {"name": "Serotonin", "prefix": "serotonin 5-HT7 (Ki 6.3 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT2C (Ki 9.4 nM), dopamine "}, {"name": "Serotonin", "prefix": ", adrenergic \u03b12A (Ki 90 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT3 (Ki 95 nM), serotonin 5"}, {"name": "Serotonin", "prefix": " serotonin 5-HT3 (Ki 95 nM), ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "serotonin", "suffix": " 5-HT1A (Ki 120 nM), dopamine "}, {"name": "Clozaril", "prefix": " type 2A (5-HT2A) receptors. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/216102", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " also acts as an antagonist at"}, {"name": "Clozaril", "prefix": "                  In humans, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/216102", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " tablets (25 mg and 100 mg) ar"}, {"name": "Clozaril", "prefix": "y bioavailable relative to a ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/216102", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " solution. Following oral admi"}, {"name": "Clozaril", "prefix": "owing oral administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/216102", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " 100 mg twice daily, the avera"}, {"name": "Clozaril", "prefix": " systemic bioavailability of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/216102", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": ". Thus, CLOZARIL may be admini"}, {"name": "Clozaril", "prefix": "ilability of CLOZARIL. Thus, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/216102", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "CLOZARIL", "suffix": " may be administered with or w"}, {"name": "Histamine", "prefix": " to the following receptors: ", "fullId": "http://purl.bioontology.org/ontology/MESH/D006632", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "histamine", "suffix": " H1 (Ki 1.1 nM), adrenergic \u03b11"}, {"name": "Histamine", "prefix": " to the following receptors: ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/5333", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "histamine", "suffix": " H1 (Ki 1.1 nM), adrenergic \u03b11"}, {"name": "Prolactin", "prefix": "lozapine causes little or no ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011388", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "prolactin", "suffix": " elevation.\n                  "}, {"name": "Prolactin", "prefix": "lozapine causes little or no ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1426890", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "prolactin", "suffix": " elevation.\n                  "}, {"name": "norclozapine", "prefix": "wn the desmethyl metabolite (", "fullId": "http://purl.bioontology.org/ontology/MESH/C058272", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "norclozapine", "suffix": ") to have only limited activit"}, {"name": "norclozapine", "prefix": "ozapine and its metabolites, ", "fullId": "http://purl.bioontology.org/ontology/MESH/C058272", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "N-desmethylclozapine", "suffix": " and clozapine N-oxide, were e"}, {"name": "Fluvoxamine", "prefix": " \n                           ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/42355", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Fluvoxamine", "suffix": " \n                        \n   "}, {"name": "Fluvoxamine", "prefix": "s. After coadministration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/42355", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "fluvoxamine", "suffix": " for 14 days, mean trough conc"}, {"name": "Fluvoxamine", "prefix": " \n                           ", "fullId": "http://purl.bioontology.org/ontology/MESH/D016666", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Fluvoxamine", "suffix": " \n                        \n   "}, {"name": "Fluvoxamine", "prefix": "s. After coadministration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D016666", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "fluvoxamine", "suffix": " for 14 days, mean trough conc"}, {"name": "Paroxetine", "prefix": " \n                           ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Paroxetine", "suffix": ", Fluoxetine, and Sertraline\n "}, {"name": "Paroxetine", "prefix": "ditions, coadministration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "paroxetine", "suffix": " produced only minor changes i"}, {"name": "Paroxetine", "prefix": "hen clozapine was taken with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/32937", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "paroxetine", "suffix": ", fluoxetine, and sertraline.\n"}, {"name": "Paroxetine", "prefix": " \n                           ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Paroxetine", "suffix": ", Fluoxetine, and Sertraline\n "}, {"name": "Paroxetine", "prefix": "ditions, coadministration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "paroxetine", "suffix": " produced only minor changes i"}, {"name": "Paroxetine", "prefix": "hen clozapine was taken with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017374", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "paroxetine", "suffix": ", fluoxetine, and sertraline.\n"}, {"name": "Fluoxetine", "prefix": "                 Paroxetine, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D005473", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Fluoxetine", "suffix": ", and Sertraline\n             "}, {"name": "Fluoxetine", "prefix": "e was taken with paroxetine, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D005473", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "fluoxetine", "suffix": ", and sertraline.\n            "}, {"name": "Fluoxetine", "prefix": "                 Paroxetine, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/4493", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Fluoxetine", "suffix": ", and Sertraline\n             "}, {"name": "Fluoxetine", "prefix": "e was taken with paroxetine, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/4493", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "fluoxetine", "suffix": ", and sertraline.\n            "}, {"name": "Sertraline", "prefix": " Paroxetine, Fluoxetine, and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Sertraline", "suffix": "\n                        \n    "}, {"name": "Sertraline", "prefix": " paroxetine, fluoxetine, and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "sertraline", "suffix": ".\n                        \n   "}, {"name": "Sertraline", "prefix": " Paroxetine, Fluoxetine, and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "Sertraline", "suffix": "\n                        \n    "}, {"name": "Sertraline", "prefix": " paroxetine, fluoxetine, and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "5f0c6f5f-b906-4c8f-8580-3939a476a1c1", "exact": "sertraline", "suffix": ".\n                        \n   "}, {"name": "Sertraline", "prefix": "d to Plasma Proteins\u2013Because ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " is tightly bound to plasma pr"}, {"name": "Sertraline", "prefix": "otein, the administration of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline hydrochloride", "suffix": " to a patient taking another d"}, {"name": "Sertraline", "prefix": "isplacement of protein bound ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " by other tightly bound drugs."}, {"name": "Sertraline", "prefix": "1 days of dosing with either ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " (50 to 200 mg/day) or placebo"}, {"name": "Sertraline", "prefix": " 8% relative to baseline for ", "fullId": "http://purl.bioontology.org/ontology/MESH/D020280", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " compared to a 1% decrease for"}, {"name": "Sertraline", "prefix": "d to Plasma Proteins\u2013Because ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " is tightly bound to plasma pr"}, {"name": "Sertraline", "prefix": "isplacement of protein bound ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " by other tightly bound drugs."}, {"name": "Sertraline", "prefix": "1 days of dosing with either ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " (50 to 200 mg/day) or placebo"}, {"name": "Sertraline", "prefix": " 8% relative to baseline for ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/36437", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline", "suffix": " compared to a 1% decrease for"}, {"name": "Sertraline Hydrochloride", "prefix": "otein, the administration of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/155137", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "sertraline hydrochloride", "suffix": " to a patient taking another d"}, {"name": "Warfarin", "prefix": "htly bound to protein (e.g., ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "warfarin", "suffix": ", digitoxin) may cause a shift"}, {"name": "Warfarin", "prefix": "20 hr) following dosing with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D014859", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "warfarin", "suffix": " (0.75 mg/kg) before and after"}, {"name": "Warfarin", "prefix": "htly bound to protein (e.g., ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "warfarin", "suffix": ", digitoxin) may cause a shift"}, {"name": "Warfarin", "prefix": "20 hr) following dosing with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/11289", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "warfarin", "suffix": " (0.75 mg/kg) before and after"}, {"name": "Digitoxin", "prefix": " to protein (e.g., warfarin, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3403", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "digitoxin", "suffix": ") may cause a shift in plasma "}, {"name": "Digitoxin", "prefix": " to protein (e.g., warfarin, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004074", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "digitoxin", "suffix": ") may cause a shift in plasma "}, {"name": "Prothrombin", "prefix": "        In a study comparing ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011516", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "prothrombin", "suffix": " time AUC (0 to 120 hr) follow"}, {"name": "Prothrombin", "prefix": "there was a mean increase in ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011516", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "prothrombin", "suffix": " time of 8% relative to baseli"}, {"name": "Prothrombin", "prefix": "        In a study comparing ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1441688", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "prothrombin", "suffix": " time AUC (0 to 120 hr) follow"}, {"name": "Prothrombin", "prefix": "there was a mean increase in ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1441688", "setId": "c25f968b-7037-4f60-9a02-2189769b0cbf", "exact": "prothrombin", "suffix": " time of 8% relative to baseli"}, {"name": "Prochlorperazine", "prefix": " an increased risk of death. ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "Prochlorperazine maleate", "suffix": " is not approved for the treat"}, {"name": "Prochlorperazine", "prefix": "which can occur secondary to ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " may be confused with the cent"}, {"name": "Prochlorperazine", "prefix": "r encephalopathy. The use of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " and other potential hepatotox"}, {"name": "Prochlorperazine", "prefix": "any phenothiazine, including ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": ", unless in the judgment of th"}, {"name": "Prochlorperazine", "prefix": "rds.\n                        ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "Prochlorperazine", "suffix": " may impair mental and/or phys"}, {"name": "Prochlorperazine", "prefix": "       Safety for the use of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " during pregnancy has not been"}, {"name": "Prochlorperazine", "prefix": "been established. Therefore, ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " is not recommended for use in"}, {"name": "Prochlorperazine", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "Prochlorperazine Maleate", "suffix": " should be used during pregnan"}, {"name": "Prochlorperazine", "prefix": "ion should be exercised when ", "fullId": "http://purl.bioontology.org/ontology/MESH/D011346", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " is administered to a nursing "}, {"name": "Prochlorperazine Maleate", "prefix": " an increased risk of death. ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8706", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "Prochlorperazine maleate", "suffix": " is not approved for the treat"}, {"name": "Prochlorperazine Maleate", "prefix": "                             ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8706", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "Prochlorperazine Maleate", "suffix": " should be used during pregnan"}, {"name": "Prochlorperazine", "prefix": "which can occur secondary to ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " may be confused with the cent"}, {"name": "Prochlorperazine", "prefix": "r encephalopathy. The use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " and other potential hepatotox"}, {"name": "Prochlorperazine", "prefix": "any phenothiazine, including ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": ", unless in the judgment of th"}, {"name": "Prochlorperazine", "prefix": "rds.\n                        ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "Prochlorperazine", "suffix": " may impair mental and/or phys"}, {"name": "Prochlorperazine", "prefix": "       Safety for the use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " during pregnancy has not been"}, {"name": "Prochlorperazine", "prefix": "been established. Therefore, ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " is not recommended for use in"}, {"name": "Prochlorperazine", "prefix": "ion should be exercised when ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/8704", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "prochlorperazine", "suffix": " is administered to a nursing "}, {"name": "phenothiazine", "prefix": "dyscrasias, jaundice) with a ", "fullId": "http://purl.bioontology.org/ontology/MESH/C031637", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "phenothiazine", "suffix": " should not receive any phenot"}, {"name": "phenothiazine", "prefix": "azine should not receive any ", "fullId": "http://purl.bioontology.org/ontology/MESH/C031637", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": "phenothiazine", "suffix": ", including prochlorperazine, "}, {"name": "alcohol,", "prefix": "ous system depressants (e.g.,", "fullId": "Added locally", "setId": "a971ea18-40cf-4a01-b696-180ccc3fddb5", "exact": " alcohol", "suffix": ", anesthetics, narcotics).\n   "}, {"name": "vortioxetine", "prefix": "        \u2022Hypersensitivity to ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1455099", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "vortioxetine", "suffix": " or any components of the form"}, {"name": "vortioxetine", "prefix": "        \u2022Hypersensitivity to ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1455099", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "vortioxetine", "suffix": " or any components of the BRIN"}, {"name": "vortioxetine", "prefix": "        \u2022Hypersensitivity to ", "fullId": "http://purl.bioontology.org/ontology/MESH/C557874", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "vortioxetine", "suffix": " or any components of the form"}, {"name": "vortioxetine", "prefix": "        \u2022Hypersensitivity to ", "fullId": "http://purl.bioontology.org/ontology/MESH/C557874", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "vortioxetine", "suffix": " or any components of the BRIN"}, {"name": "Brintellix", "prefix": "ted in patients treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": ".\n                     \n      "}, {"name": "Brintellix", "prefix": "t psychiatric disorders with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " or within 21 days of stopping"}, {"name": "Brintellix", "prefix": "s of stopping treatment with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " is contraindicated because of"}, {"name": "Brintellix", "prefix": "rotonin syndrome. The use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " within 14 days of stopping an"}, {"name": "Brintellix", "prefix": "                   \u00a0Starting ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " in a patient who is being tre"}, {"name": "Brintellix", "prefix": "ine or any components of the ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " formulation (4).\n            "}, {"name": "Brintellix", "prefix": "t psychiatric disorders with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " or within 21 days of stopping"}, {"name": "Brintellix", "prefix": "s of stopping treatment with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": ". Do not use BRINTELLIX within"}, {"name": "Brintellix", "prefix": " with BRINTELLIX. Do not use ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " within 14 days of stopping an"}, {"name": "Brintellix", "prefix": "s. In addition, do not start ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1439824", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "BRINTELLIX", "suffix": " in a patient who is being tre"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "serotonin", "suffix": " syndrome. The use of BRINTELL"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/1311214", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "serotonin", "suffix": " syndrome [see Dosage and Admi"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "serotonin", "suffix": " syndrome. The use of BRINTELL"}, {"name": "Serotonin", "prefix": "ause of an increased risk of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D012701", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "serotonin", "suffix": " syndrome [see Dosage and Admi"}, {"name": "linezolid", "prefix": "g treated with MAOIs such as ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/190376", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "linezolid", "suffix": " or intravenous methylene blue"}, {"name": "linezolid", "prefix": "nt who is being treated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/190376", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "linezolid", "suffix": " or intravenous methylene blue"}, {"name": "linezolid", "prefix": "g treated with MAOIs such as ", "fullId": "http://purl.bioontology.org/ontology/MESH/C098010", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "linezolid", "suffix": " or intravenous methylene blue"}, {"name": "linezolid", "prefix": "nt who is being treated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/C098010", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "linezolid", "suffix": " or intravenous methylene blue"}, {"name": "Methylene Blue", "prefix": " as linezolid or intravenous ", "fullId": "http://purl.bioontology.org/ontology/MESH/D008751", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "methylene blue", "suffix": " is also contraindicated becau"}, {"name": "Methylene Blue", "prefix": "ith linezolid or intravenous ", "fullId": "http://purl.bioontology.org/ontology/MESH/D008751", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "methylene blue", "suffix": " (4).\n                        "}, {"name": "Methylene blue", "prefix": " as linezolid or intravenous ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6878", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "methylene blue", "suffix": " is also contraindicated becau"}, {"name": "Methylene blue", "prefix": "ith linezolid or intravenous ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6878", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "methylene blue", "suffix": " (4).\n                        "}, {"name": "maoi", "prefix": "                  \u2022The use of", "fullId": "Added locally", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": " MAO", "suffix": "Is intended to treat psychiatr"}, {"name": "maoi", "prefix": "within 14 days of stopping an", "fullId": "Added locally", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": " MAO", "suffix": "I intended to treat psychiatri"}, {"name": "maoi", "prefix": "ent who is being treated with", "fullId": "Added locally", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": " MAO", "suffix": "Is such as linezolid or intrav"}, {"name": "maoi", "prefix": "Monoamine Oxidase Inhibitors ", "fullId": "Added locally", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": "(MAO", "suffix": "Is): Do not use MAOIs intended"}, {"name": "maoi", "prefix": "nhibitors (MAOIs): Do not use", "fullId": "Added locally", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": " MAO", "suffix": "Is intended to treat psychiatr"}, {"name": "maoi", "prefix": "within 14 days of stopping an", "fullId": "Added locally", "setId": "4b0700c9-b417-4c3a-b36f-de461e125bd3", "exact": " MAO", "suffix": "I intended to treat psychiatri"}, {"name": "Benzodiazepines", "prefix": "          \n                  ", "fullId": "http://purl.bioontology.org/ontology/MESH/D001569", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "Benzodiazepines", "suffix": " may cause fetal damage when a"}, {"name": "Benzodiazepines", "prefix": "on of therapeutic doses of a ", "fullId": "http://purl.bioontology.org/ontology/MESH/D001569", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "benzodiazepine", "suffix": " hypnotic during the last week"}, {"name": "Diazepam", "prefix": "s associated with the use of ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/3322", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "diazepam", "suffix": " and chlordiazepoxide during t"}, {"name": "Diazepam", "prefix": "s associated with the use of ", "fullId": "http://purl.bioontology.org/ontology/MESH/D003975", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "diazepam", "suffix": " and chlordiazepoxide during t"}, {"name": "Chlordiazepoxide", "prefix": "with the use of diazepam and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D002707", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "chlordiazepoxide", "suffix": " during the first trimester of"}, {"name": "Chlordiazepoxide", "prefix": "with the use of diazepam and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/2356", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "chlordiazepoxide", "suffix": " during the first trimester of"}, {"name": "Estazolam", "prefix": "pregnancy.\n                  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/4077", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "Estazolam", "suffix": " is contraindicated in pregnan"}, {"name": "Estazolam", "prefix": "ing pregnant while receiving ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/4077", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "estazolam", "suffix": " she should be warned of the p"}, {"name": "Estazolam", "prefix": "onsidered.\n                  ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/4077", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "Estazolam", "suffix": " is contraindicated with ketoc"}, {"name": "Estazolam", "prefix": "pregnancy.\n                  ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004949", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "Estazolam", "suffix": " is contraindicated in pregnan"}, {"name": "Estazolam", "prefix": "ing pregnant while receiving ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004949", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "estazolam", "suffix": " she should be warned of the p"}, {"name": "Estazolam", "prefix": "onsidered.\n                  ", "fullId": "http://purl.bioontology.org/ontology/MESH/D004949", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "Estazolam", "suffix": " is contraindicated with ketoc"}, {"name": "Ketoconazole", "prefix": "olam is contraindicated with ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/6135", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "ketoconazole", "suffix": " and itraconazole, since these"}, {"name": "Ketoconazole", "prefix": "olam is contraindicated with ", "fullId": "http://purl.bioontology.org/ontology/MESH/D007654", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "ketoconazole", "suffix": " and itraconazole, since these"}, {"name": "Itraconazole", "prefix": "icated with ketoconazole and ", "fullId": "http://purl.bioontology.org/ontology/RXNORM/28031", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "itraconazole", "suffix": ", since these medications sign"}, {"name": "Itraconazole", "prefix": "icated with ketoconazole and ", "fullId": "http://purl.bioontology.org/ontology/MESH/D017964", "setId": "50914a46-eab6-4c83-97cf-6ab0234c8126", "exact": "itraconazole", "suffix": ", since these medications sign"}]